IFI27

SpeeDx Partners with Nepean Hospital to Commercialise Respiratory Virus Host Biomarker Assay

SpeeDx newly patented InSignia technology simplifies the measurement of gene expression and will underpin the creation of a simple, standardized…

Read More »